Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection
Description
Infectious virus shedding from individuals infected with severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is used to estimate human-to-human transmission risk. Control of SARS-CoV-2 transmission requires identifying the immune correlates
